237 related articles for article (PubMed ID: 37449837)
1. Opto-RhoGEFs, an optimized optogenetic toolbox to reversibly control Rho GTPase activity on a global to subcellular scale, enabling precise control over vascular endothelial barrier strength.
Mahlandt EK; Palacios Martínez S; Arts JJG; Tol S; van Buul JD; Goedhart J
Elife; 2023 Jul; 12():. PubMed ID: 37449837
[TBL] [Abstract][Full Text] [Related]
2. DOCK4 Regulation of Rho GTPases Mediates Pulmonary Vascular Barrier Function.
Yazbeck P; Cullere X; Bennett P; Yajnik V; Wang H; Kawada K; Davis VM; Parikh A; Kuo A; Mysore V; Hla T; Milstone DS; Mayadas TN
Arterioscler Thromb Vasc Biol; 2022 Jul; 42(7):886-902. PubMed ID: 35477279
[TBL] [Abstract][Full Text] [Related]
3. A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.
Timmerman I; Heemskerk N; Kroon J; Schaefer A; van Rijssel J; Hoogenboezem M; van Unen J; Goedhart J; Gadella TW; Yin T; Wu Y; Huveneers S; van Buul JD
J Cell Sci; 2015 Aug; 128(16):3041-54. PubMed ID: 26116572
[TBL] [Abstract][Full Text] [Related]
4. Small Rho GTPase-mediated actin dynamics at endothelial adherens junctions.
van Buul JD; Timmerman I
Small GTPases; 2016; 7(1):21-31. PubMed ID: 26825121
[TBL] [Abstract][Full Text] [Related]
5. Rho GAPs and GEFs: controling switches in endothelial cell adhesion.
van Buul JD; Geerts D; Huveneers S
Cell Adh Migr; 2014; 8(2):108-24. PubMed ID: 24622613
[TBL] [Abstract][Full Text] [Related]
6. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
[TBL] [Abstract][Full Text] [Related]
7. Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.
Cook DR; Rossman KL; Der CJ
Oncogene; 2014 Jul; 33(31):4021-35. PubMed ID: 24037532
[TBL] [Abstract][Full Text] [Related]
8. GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction.
Birukova AA; Adyshev D; Gorshkov B; Bokoch GM; Birukov KG; Verin AD
Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L540-8. PubMed ID: 16257999
[TBL] [Abstract][Full Text] [Related]
9. Designing Single-Component Optogenetic Membrane Recruitment Systems: The Rho-Family GTPase Signaling Toolbox.
Berlew EE; Yamada K; Kuznetsov IA; Rand EA; Ochs CC; Jaber Z; Gardner KH; Chow BY
ACS Synth Biol; 2022 Jan; 11(1):515-521. PubMed ID: 34978789
[TBL] [Abstract][Full Text] [Related]
10. Rap-afadin axis in control of Rho signaling and endothelial barrier recovery.
Birukova AA; Tian X; Tian Y; Higginbotham K; Birukov KG
Mol Biol Cell; 2013 Sep; 24(17):2678-88. PubMed ID: 23864716
[TBL] [Abstract][Full Text] [Related]
11. HGF attenuates thrombin-induced endothelial permeability by Tiam1-mediated activation of the Rac pathway and by Tiam1/Rac-dependent inhibition of the Rho pathway.
Birukova AA; Alekseeva E; Mikaelyan A; Birukov KG
FASEB J; 2007 Sep; 21(11):2776-86. PubMed ID: 17428964
[TBL] [Abstract][Full Text] [Related]
12. Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids.
Birukova AA; Malyukova I; Mikaelyan A; Fu P; Birukov KG
J Cell Physiol; 2007 Jun; 211(3):608-17. PubMed ID: 17219408
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell sprouting driven by RhoJ directly activated by a membrane-anchored Intersectin 1 (ITSN1) RhoGEF module.
Color-Aparicio VM; Cervantes-Villagrana RD; García-Jiménez I; Beltrán-Navarro YM; Castillo-Kauil A; Escobar-Islas E; Reyes-Cruz G; Vázquez-Prado J
Biochem Biophys Res Commun; 2020 Mar; 524(1):109-116. PubMed ID: 31980169
[TBL] [Abstract][Full Text] [Related]
14. Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer.
Cervantes-Villagrana RD; García-Jiménez I; Vázquez-Prado J
Cell Signal; 2023 Sep; 109():110749. PubMed ID: 37290677
[TBL] [Abstract][Full Text] [Related]
15. Gα
Castillo-Kauil A; García-Jiménez I; Cervantes-Villagrana RD; Adame-García SR; Beltrán-Navarro YM; Gutkind JS; Reyes-Cruz G; Vázquez-Prado J
J Biol Chem; 2020 Dec; 295(50):16920-16928. PubMed ID: 33023908
[TBL] [Abstract][Full Text] [Related]
16. VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost.
Birukova AA; Tian Y; Dubrovskyi O; Zebda N; Sarich N; Tian X; Wang Y; Birukov KG
J Cell Physiol; 2012 Oct; 227(10):3405-16. PubMed ID: 22213015
[TBL] [Abstract][Full Text] [Related]
17. I'm coming to GEF you: Regulation of RhoGEFs during cell migration.
Goicoechea SM; Awadia S; Garcia-Mata R
Cell Adh Migr; 2014; 8(6):535-49. PubMed ID: 25482524
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced Ca2+ sensitization in smooth muscle: redundancy of Rho guanine nucleotide exchange factors (RhoGEFs) and response kinetics, a caged compound study.
Artamonov MV; Momotani K; Stevenson A; Trentham DR; Derewenda U; Derewenda ZS; Read PW; Gutkind JS; Somlyo AV
J Biol Chem; 2013 Nov; 288(47):34030-34040. PubMed ID: 24106280
[TBL] [Abstract][Full Text] [Related]
19. The Rho guanine nucleotide exchange factor PLEKHG1 is activated by interaction with and phosphorylation by Src family kinase member FYN.
Nakano S; Nishikawa M; Kobayashi T; Harlin EW; Ito T; Sato K; Sugiyama T; Yamakawa H; Nagase T; Ueda H
J Biol Chem; 2022 Feb; 298(2):101579. PubMed ID: 35031323
[TBL] [Abstract][Full Text] [Related]
20. Endothelial RhoGEFs: A systematic analysis of their expression profiles in VEGF-stimulated and tumor endothelial cells.
Hernández-García R; Iruela-Arispe ML; Reyes-Cruz G; Vázquez-Prado J
Vascul Pharmacol; 2015 Nov; 74():60-72. PubMed ID: 26471833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
